Peter D Schellinger, Martin Köhrmann. Show Affiliations »
Abstract
Mesh： See more » Cerebral Arteries/drug effectsCerebral Arteries/pathologyCerebral Arteries/physiopathologyCost-Benefit AnalysisDiffusion Magnetic Resonance Imaging/economicsDiffusion Magnetic Resonance Imaging/methodsDiffusion Magnetic Resonance Imaging/trendsHumansIntracranial Thrombosis/diagnosisIntracranial Thrombosis/drug therapyIntracranial Thrombosis/physiopathologyMagnetic Resonance Angiography/economicsMagnetic Resonance Angiography/methodsMagnetic Resonance Angiography/trendsMass ScreeningStroke/diagnosisStroke/drug therapyStroke/physiopathologyThrombolytic Therapy/standardsTime FactorsTissue Plasminogen Activator/therapeutic useTomography, X-Ray Computed/economicsTomography, X-Ray Computed/methodsTomography, X-Ray Computed/trendsUltrasonography, Doppler, Transcranial/economicsUltrasonography, Doppler, Transcranial/methodsUltrasonography, Doppler, Transcranial/trends
Substances： See more » Tissue Plasminogen Activator
Year: 2008 PMID： 18635838 DOI： 10.1161/STROKEAHA.108.516963
Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914